'Current methods' diaporamas de présentation

Children with Developmental Apraxia of Speech Communication Profiles and Interventions

Children with Developmental Apraxia of Speech Communication Profiles and Interventions. Laura J. Ball, Ph. D. Munroe-Meyer Institute for Genetics and Rehabilitation University of Nebraska Medical Center, Omaha. Demographics. Onset Course Gender Prevalence Aggregation.

2.11k views • 112 slides

Ethan

Ethan. Questions Investigated by Psychologists. How important are parents in the development of a child? Why do individuals remain in abusive relationships? Is depression caused by a chemical imbalance? What are the long-term consequences of sexual assault?

1.26k views • 98 slides

The Personal Software Process (PSP) Lecture #1

770 views • 60 slides

Tight Clustering: a method for extracting stable and tight patterns in expression profiles

Tight Clustering: a method for extracting stable and tight patterns in expression profiles. A class of penalized and weighted K-means for clustering. George C. Tseng Dept. of Biostatistics & Human Genetics University of Pittsburgh. Image analysis. Normalization. Identify differentially

795 views • 52 slides

Background

645 views • 51 slides

Statistics for Microarrays

602 views • 46 slides

Team Purple 2.009 Final Presentation December 12, 2005

Team Purple 2.009 Final Presentation December 12, 2005. Overview. 1 billion subsistence farmers Inefficient irrigation Starvation Poverty The IrriGator Pump Human-powered water pump Low cost Ergonomic Business model Economically viable Self-sustaining non-profit.

454 views • 30 slides

A Heavy-Duty Vehicle Visual Classification Scheme: Heavy-Duty Vehicle Reclassification Method for Mobile Source Emissio

A Heavy-Duty Vehicle Visual Classification Scheme: Heavy-Duty Vehicle Reclassification Method for Mobile Source Emissions Inventory Development. Prepared for CEE6792 Seungju Yoon. OUTLINE. Background Objectives Current HDV classification schemes HDV weight regulation

513 views • 24 slides

Meeting the Safety Needs of a Dynamic Organization

Meeting the Safety Needs of a Dynamic Organization. RADM Mark Tedesco, MD, MPH, FS, USPHS Director, Health, Safety and Work-Life U. S. Coast Guard. The Risk Continuum. Increase in Diversity/Complexity of Missions Aviation Rotary Wing Aerial Intercept Expansion of Airborne Use of Force

341 views • 21 slides

359 views • 20 slides

Labeling on Everything - EPC, PML and ONS

Labeling on Everything - EPC, PML and ONS. Manufacturing Automation & Integration Lab. 2004. 7. 30. Manchul Han (sampleh@ultra.snu.ac.kr). * EPC: Electronic Product Code * PML: Physical Markup Language * ONS: Object Name Service. Contents. The Intelligent Infrastructure

397 views • 19 slides

Nanoscale structures in Integrated Circuits

Nanoscale structures in Integrated Circuits. By Edward Mulimba. Presentation Outline . Introduction and history Review of current chip manufacturing methods Limitations of current methods 2 currently researched methods conclusion. Nanotech Definition.

223 views • 19 slides

Place name of trainer

283 views • 18 slides

347 views • 16 slides

Why Should Military Food Suppliers Be Concerned with Sustainable Packaging?

Why Should Military Food Suppliers Be Concerned with Sustainable Packaging?. November , 2009 Kay Cooksey, Ph.D. Professor, Cryovac Chair Clemson University. Is this a lasting trend?. Cradle to Cradle Book published in 2002 GreenBlue started about same time

263 views • 16 slides

Information Sharing Mechanisms

244 views • 14 slides

Wind Loads: The Nature of Wind

1.24k views • 12 slides

Algae Biofuel

467 views • 12 slides

ASSESSING RISK

ASSESSING RISK. RISK - THE POSSIBILITY THAT SOME LOSS MIGHT OCCUR. WHAT ARE THE CAUSES OF RISK? WHAT ARE THE EFFECTS OF RISK ON THE BUSINESS? HOW CAN WE CONTROL RISK?. SOURCES OF RISK. PRODUCTION AND YIELD MARKET AND PRICE BUSINESS AND FINANCIAL TECHNOLOGY AND OBSOLESCENCE

218 views • 9 slides

Bioequivalence of Inhalation Drug Products: Challenges and Opportunities

Bioequivalence of Inhalation Drug Products: Challenges and Opportunities. Lawrence X. Yu, Ph.D. Director for Science Office of Generic Drugs, OPS, CDER Food and Drug Administration. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology 23 July 2008.

580 views • 7 slides